Cristine Delnevo, director of the Rutgers Center for Tobacco Studies and a professor of Health Behavior, Society and Policy at the Rutgers School of Public Health, has been appointed chairperson of the U.S. Food and Drug Administration’s (FDA) Tobacco Products Scientific Advisory Committee (TPSAC). Her appointment as chair will run through Jan. 31, 2025.
Delnevo was appointed to serve on the committee in March 2021. Established in 2009, TPSAC reviews and evaluates safety, dependence and health issues related to tobacco products and provides advice, information and recommendations to the FDA’s commissioner. The FDA commissioner selects the committee members from among people with expertise in medicine, medical ethics, science or technology involving the manufacture, evaluation or use of tobacco products.
“I have valued the importance of this FDA advisory committee since the signing of the Family Smoking Prevention and Tobacco Control Act in 2009,” said Delnevo in a press note published by Rutgers. “This advisory committee plays an important role in several ways, perhaps most notably on the review of modified risk tobacco product applications, as required under the Tobacco Control Act.”
Delnevo’s expertise spans population-level tobacco behavior trends, particularly non-cigarette tobacco products like cigars and e-cigarettes, tobacco control policy and regulation, and survey methods research.